BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 33269400)

  • 1. Genotypic diversity and antifungal susceptibility of environmental isolates of Cryptococcus neoformans from the Yangtze River Delta region of East China.
    Chen M; Wang Y; Li Y; Hong N; Zhu X; Pan W; Liao W; Xu J; Du J; Chen J
    Med Mycol; 2021 Jul; 59(7):653-663. PubMed ID: 33269400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans isolates from paediatric patients in China.
    Hong N; Chen M; Xu N; Al-Hatmi AMS; Zhang C; Pan WH; Hagen F; Boekhout T; Xu J; Zou XB; Liao WQ
    Mycoses; 2019 Feb; 62(2):171-180. PubMed ID: 30341799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotypic diversity in clinical and environmental isolates of Cryptococcus neoformans from India using multilocus microsatellite and multilocus sequence typing.
    Prakash A; Sundar G; Sharma B; Hagen F; Meis JF; Chowdhary A
    Mycoses; 2020 Mar; 63(3):284-293. PubMed ID: 31820495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in China.
    Fan X; Xiao M; Chen S; Kong F; Dou HT; Wang H; Xiao YL; Kang M; Sun ZY; Hu ZD; Wan Z; Chen SL; Liao K; Chu YZ; Hu TS; Zou GL; Hou X; Zhang L; Zhao YP; Xu YC; Liu ZY
    Clin Microbiol Infect; 2016 Oct; 22(10):887.e1-887.e9. PubMed ID: 27432767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization and antifungal susceptibility testing of Cryptococcus neoformans sensu stricto from southern Brazil.
    Herkert PF; Meis JF; Lucca de Oliveira Salvador G; Rodrigues Gomes R; Aparecida Vicente V; Dominguez Muro M; Lameira Pinheiro R; Lopes Colombo A; Vargas Schwarzbold A; Sakuma de Oliveira C; Simão Ferreira M; Queiroz-Telles F; Hagen F
    J Med Microbiol; 2018 Apr; 67(4):560-569. PubMed ID: 29461182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-locus sequence typing reveals genotypic similarity in Nigerian
    Chidebelu PE; Nweze EI; Meis JF; Cogliati M; Hagen F
    J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34665109
    [No Abstract]   [Full Text] [Related]  

  • 7. Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans species complex from China, including the diploid VNIII isolates from HIV-infected patients in Chongqing region.
    Zhang L; Wang S; Hong N; Li M; Liu Y; Zhou T; Peng Y; Hu C; Li X; Zhang Z; Guo M; Cogliati M; Hitchcock M; Xu J; Chen M; Liao G
    Med Mycol; 2023 Dec; 61(12):. PubMed ID: 37985734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the
    Yang C; Bian Z; Blechert O; Deng F; Chen H; Li Y; Yang Y; Chen M; Zhan P
    Front Cell Infect Microbiol; 2021; 11():723251. PubMed ID: 34790585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
    Hagen F; Hare Jensen R; Meis JF; Arendrup MC
    Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotypic diversity of Iranian Cryptococcus neoformans using multilocus sequence typing (MLST) and susceptibility to antifungals.
    Moslem M; Fatahinia M; Kiasat N; Mahmoudabadi AZ
    Mol Biol Rep; 2021 May; 48(5):4201-4208. PubMed ID: 34057687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular typing and antifungal susceptibility of clinical and environmental Cryptococcus neoformans species complex isolates in Goiania, Brazil.
    Souza LK; Souza Junior AH; Costa CR; Faganello J; Vainstein MH; Chagas AL; Souza AC; Silva MR
    Mycoses; 2010 Jan; 53(1):62-7. PubMed ID: 19500261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.
    Selb R; Fuchs V; Graf B; Hamprecht A; Hogardt M; Sedlacek L; Schwarz R; Idelevich EA; Becker SL; Held J; Küpper-Tetzel CP; McCormick-Smith I; Heckmann D; Gerkrath J; Han CO; Wilmes D; Rickerts V
    Int J Med Microbiol; 2019 Sep; 309(6):151336. PubMed ID: 31444102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic diversity of environmental Cryptococcus neoformans isolates from Northern Portugal.
    Ferreira AS; Sampaio A; Maduro AP; Silva I; Teles F; Martins Mda L; Inácio J
    Mycoses; 2014 Feb; 57(2):98-104. PubMed ID: 23848429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical epidemiology and high genetic diversity amongst Cryptococcus spp. isolates infecting people living with HIV in Kinshasa, Democratic Republic of Congo.
    Bive BZ; Sacheli R; Situakibanza Nani-Tuma H; Kabututu Zakayi P; Ka A; Mbula Mambimbi M; Muendele G; Boreux R; Landu N; Nzanzu Mudogo C; M'Buze PR; Moutschen M; Meyer W; Mvumbi Lelo G; Hayette MP
    PLoS One; 2022; 17(5):e0267842. PubMed ID: 35587939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of Cryptococcus neoformans isolated from the environment in Beijing, China.
    Dou H; Wang H; Xie S; Chen X; Xu Z; Xu Y
    Med Mycol; 2017 Oct; 55(7):737-747. PubMed ID: 28431114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of clinical and environmental isolates from the Cryptococcus neoformans/C. Gattii species complexes of Maceió, Alagoas, Brazil.
    de Holanda Fonseca DL; Silva DMWD; de Albuquerque Maranhão FC
    Braz J Microbiol; 2024 Jun; 55(2):1369-1380. PubMed ID: 38619732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular epidemiology and antifungal susceptibility profiles of clinical
    Bandalizadeh Z; Shokohi T; Badali H; Abastabar M; Babamahmoudi F; Davoodi L; Mardani M; Javanian M; Cheraghmakani H; Sepidgar AA; Badiee P; Khodavaisy S; Afshari SAK; Ahmadikia K; Seyedmousavi S
    J Med Microbiol; 2020 Jan; 69(1):72-81. PubMed ID: 31750814
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular characterization of environmental Cryptococcus neoformans VNII isolates in Jos, Plateau State, Nigeria.
    Nnadi NE; Enweani IB; Cogliati M; Ayanbimpe GM; Okolo MO; Kim E; Sabitu MZ; Criseo G; Romeo O; Scordino F
    J Mycol Med; 2016 Dec; 26(4):306-311. PubMed ID: 27184613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal susceptibility of clinical and environmental Cryptococcus neoformans and Cryptococcus gattii isolates in Jabalpur, a city of Madhya Pradesh in Central India.
    Gutch RS; Nawange SR; Singh SM; Yadu R; Tiwari A; Gumasta R; Kavishwar A
    Braz J Microbiol; 2015; 46(4):1125-33. PubMed ID: 26691471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behaviour azole fungicide and fluconazole in Cryptococcus neoformans clinical and environmental isolates].
    Drummond ED; Reimão JQ; Dias AL; de Siqueira AM
    Rev Soc Bras Med Trop; 2007; 40(2):209-11. PubMed ID: 17568890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.